SCHEMBL19001629

SCHEMBL19001629

C=N/C(C)=N\C=C(/C)c1ccccn1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.46
▸ ALDH1A1 P00352 3/20 0.44
▸ CES2 O00748 1/20 0.39
▸ CES1 P23141 1/20 0.39
▸ LMNA P02545 1/20 0.38
▸ NAPRT Q6XQN6 1/20 0.38
▸ P4HTM Q9NXG6 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ RAB9A P51151 7/20 0.37
▸ SMN1; SMN2 Q16637 3/20 0.37
▸ TDP1 Q9NUW8 2/20 0.37
▸ PTBP1 P26599 1/20 0.37
▸ OPRK1 P41145 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ TOP2A P11388 1/20 0.37
▸ NPC1 O15118 4/20 0.37
▸ AGTR1 P30556 2/20 0.37
▸ MAPT P10636 2/20 0.36
▸ HSP90AA1 P07900 2/20 0.36
▸ CASP3 P42574 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23343244 0.83 KDM4E (0.52) KDM4EALDH1A1CES2CES1LMNA
SCHEMBL23437627 0.76 MEN1 (0.41) KDM4EALDH1A1LMNARAB9ASMN1; SMN2
SCHEMBL24592691 0.76 PGR (0.40) KDM4EALDH1A1LMNAL3MBTL1RAB9A
SCHEMBL18738976 0.75 KDM4E (0.47) KDM4EALDH1A1CES2CES1LMNA
SCHEMBL20402442 0.74 KDM4E (0.46) KDM4EALDH1A1CES2CES1LMNA
SCHEMBL19018493 0.74 KDM1A (0.37) CES2CES1LMNAL3MBTL1SMN1; SMN2
SCHEMBL6158138 0.73 ALDH1A1 (0.55) KDM4EALDH1A1CES2CES1LMNA
SCHEMBL3729714 0.73 ALDH1A1 (0.59) KDM4EALDH1A1CES2CES1LMNA
SCHEMBL3729713 0.73 ALDH1A1 (0.59) KDM4EALDH1A1CES2CES1LMNA
SCHEMBL9160142 0.73 ALDH1A1 (0.59) KDM4EALDH1A1CES2CES1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11018304-B2 Organic light-emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2021-05-25 — — US disclosed
US-10916708-B2 Condensed cyclic compound and organic light emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2021-02-09 — — US disclosed
US-20200259086-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2020-08-13 — — US disclosed
US-20170179404-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-22 — — US disclosed
US-20170179396-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170179404-A1 ORGANIC LIGHT-EMITTING DEVICE OR51E2, OCIAD1, OXA1L KDM4E 1773/4885ALDH1A1 32/4885CES2 1293/4885
US-10916708-B2 Condensed cyclic compound and organic light emitting device including the same C1S, C9, CCNT1 KDM4E 4309/4885ALDH1A1 163/4885CES2 1417/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback